Banque Cantonale Vaudoise Sop Hi A Genetics Sa Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$4.46 - $5.55 $40,140 - $49,950	9,000 Added 300.0%	12,000 $55,000
Q1 2024 Apr 10, 2024	SELL	$4.21 - $5.62 $24,839 - $33,158	-5,900 Reduced 66.29%	3,000 $15,000
Q3 2023 Nov 08, 2023	SELL	$2.3 - $4.58 $2,300 - $4,580	-1,000 Reduced 10.1%	8,900 $23,000
Q2 2023 Aug 09, 2023	SELL	$3.84 - $5.3 $69,120 - $95,400	-18,000 Reduced 64.52%	9,900 $43,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $2.98 $13,680 - $23,840	8,000 Added 40.2%	27,900 $57,000
Q2 2022 Aug 02, 2022	BUY	$2.46 - $7.91 $7,380 - $23,730	3,000 Added 17.75%	19,900 $73,000
Q1 2022 May 09, 2022	BUY	$7.31 - $15.6 $50,439 - $107,640	6,900 Added 69.0%	16,900 $130,000
Q4 2021 Feb 14, 2022	BUY	$12.35 - $18.8 $123,500 - $188,000	10,000 New	10,000 $141,000

18.6M

5.9K

300

Ticker SOPH
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 64,153,700
Market Cap $212M
Description
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.